NEW YORK (PRWEB)
September 14, 2017
Enovap, developer of the world’s first smart personal vaporizer able to automatically and manually control nicotine delivery, joins The Blinc Group incubator. Their mission is to introduce Enovap’s technology to investors and strengthen their presence on the U.S. market.
Enovap is bringing state of the art technology to the fight against tobacco, developing the first nicotine management system, thanks to their patented ‘double-tank technology.’ Enovap’s Hit Control system lets users control the nicotine concentration for each puff, optimizing the throat hit sensation and regulating their daily intake of nicotine, optimally relieving cravings. The company has been awarded with a range of prestigious awards, including the Seal of Excellence of the European Commission and the Ilab prize by the French Minister of Research and Innovation.
Alexandre Scheck, CEO of Enovap, explains “Enovap is aiming for a fast commercial expansion of its vaping product in the U.S. Joining The Blinc Group is the perfect opportunity to introduce our technology to players and investors in the field and accelerate our launch in the US market.”
Marie Harang-Elz, PhD., will also be joining The Blinc Group’s Advisory Board. She received her doctorate in the department of Pharmaceutical Sciences at King’s College, studying pressurized metered dose inhalers for the treatment of lung diseases, and went on to manage several commercial projects for the Vype brand and joined Enovap as a scientific developer.
Harang-Eltz, PhD., adds the engagement is “also the chance for us to share our experience and knowledge on vaping and learn from the ongoing U.S. research on vaping and cannabis. We are looking forward to meeting scientists, key opinion leaders and companies to conduct more effective research in this area to help in the development of better nicotine and cannabis delivery vaping technologies.”
Arnaud Dumas de Rauly, Chief Strategy Officer of The Blinc Group says that “Enovap represents a game-changing technology with regards to harm reduction and its applications are infinite, ranging from traditional vaping all the way to medicinal marijuana delivery as well as traditional drug delivery.”